Cargando…

Does antipsychotic therapy prevent the development of chronic psychotic disorders in people addicted to ilegal psychoactive substances

INTRODUCTION: Acute psychotic disorders are increasingly being diagnosed in people addicted to PASA part of these patients develops chronic psychotic disorders for reasons that still insufficently known. OBJECTIVES: The aim of the study was to determine preventive potential of antipsychotics in the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kasper, S. S., Čustović, A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2023
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10661340/ http://dx.doi.org/10.1192/j.eurpsy.2023.1412

Ejemplares similares

Novel Psychoactive Substances and Behavioral Addictions
por: Martinotti, Giovanni, et al.
Publicado: (2014)

Trabajo ilegal
por: Oliva, Oscar, 1937-
Publicado: (1994)

La monarca ilegal /
por: Morales, Miriam, 1952-
Publicado: (2000)

Emotional disorder dynamics for patients depending on psychoactive substances at the stages of psychosocial rehabilitation
por: Mykhaylov, B., et al.
Publicado: (2021)

The impact of the COVID pandemic on the treatment of psychoactive drug addicts in Zenica-Doboj Canton of BiH april 2020-april 2021
por: Kasper, S.
Publicado: (2022)

Psychoactive substance use among medical residents in Tunisia
por: Masmoudi, R., et al.
Publicado: (2022)

Consequences of COVID-19 Lockdown on the Misuse and Marketing of Addictive Substances and New Psychoactive Substances
por: Di Trana, Annagiulia, et al.
Publicado: (2020)

S150. DOPAMINE SYNTHESIS CAPACITY IN ANTIPSYCHOTIC NAïVE FIRST EPISODE PSYCHOTIC PATIENTS
por: Sigvard, Anne, et al.
Publicado: (2018)

Comparative study of psychoactive substance use pattern in romania and hungary
por: Costescu, C.R., et al.
Publicado: (2021)

Effectiveness of antipsychotics in schizophrenia with comorbid substance use disorder
por: Lähteenvuo, M., et al.
Publicado: (2021)

ANALYTICALLY CONFIRMED PRESENCE OF PSYCHOACTIVE SUBSTANCES, ESPECIALLY NEW PSYCHOACTIVE SUBSTANCES IN A GROUP OF PATIENTS HOSPITALIZED WITH MENTAL AND BEHAVIOURAL DISORDERS DUE TO THE USE OF PSYCHOACTIVE SUBSTANCES DIAGNOSIS
por: Engelgardt, Piotr, et al.
Publicado: (2022)

Textos legibles y ritmos ilegibles
por: Landau, Myra

Psychoactive Substance Use Among Middle-Aged and Older Adults With Visual Impairment
por: Lopez, Francisco, et al.
Publicado: (2021)

Epidemiological patterns of new psychoactive substances use in Tunisian school adolescents, 2021
por: Silini, A., et al.
Publicado: (2023)

Suicidality and self-injury behaviours due to the use of Novel Psychoactive Substances (NPS)
por: Orsolini, L.
Publicado: (2023)

AddictedChem: A Data-Driven Integrated Platform for New Psychoactive Substance Identification
por: Han, Mengying, et al.
Publicado: (2022)

Privación ilegal de la libertad física
por: Hernández Sánchez, Martín Raymundo
Publicado: (2011)

Voluntary interruption of psychotic pregnancy: Use of antipsychotic drugs in a bioethical case
por: Galvañ, J., et al.
Publicado: (2021)

Pharmacogenetic markers to predict safety of antipsychotics in adolescents experiencing acute psychotic episodes
por: Ivashchenko, D., et al.
Publicado: (2022)

Psychotic symptoms and its associated factors relating to psychoactive substance use among the youth population in Northwest Ethiopia
por: Kassew, Tilahun, et al.
Publicado: (2023)

Knowledge and Use of Novel Psychoactive Substances in an Italian Sample with Substance Use Disorders
por: Dal Farra, Deborah, et al.
Publicado: (2022)

In Silico Investigations into the Selectivity of Psychoactive and New Psychoactive Substances in Monoamine Transporters
por: Botha, Michelle J., et al.
Publicado: (2022)

Oncologists’ beliefs about people with psychotic disorders : a qualitative study
por: Le Glaz, A., et al.
Publicado: (2022)

New Psychoactive Substances Consumption in Opioid-Use Disorder Patients
por: Alías-Ferri, Maria, et al.
Publicado: (2022)

Risk factors for psychotic relapse in chronic schizophrenia after dose-reduction or discontinuation of antipsychotics. A systematic review and meta-analysis
por: Bogers, J., et al.
Publicado: (2021)

Nadie es ilegal : combatiendo el racismo y la violencia de Estado en la frontera Estados Unidos-México
por: Akers Chacón, Justin

Depression, distress and their association with patterns of psychoactive substance use during the COVID-19 emergency state in latvia
por: Vrublevska, J., et al.
Publicado: (2021)

Thought Suppression in Primary Psychotic Disorders and Substance/Medication Induced Psychotic Disorder
por: Popa, Cosmin O., et al.
Publicado: (2020)

An integrated addictions nursing subspecialty to expand the opioid use disorder and substance use disorder workforce
por: Williams, K., et al.
Publicado: (2021)

Editorial: Pharmacology of new psychoactive substances
por: Lutfy, K., et al.
Publicado: (2023)

Clinical and biochemical parameters associated with substance-induced psychotic disorder: which differences between alcohol, cannabis and psychostimulants
por: Nosari, G., et al.
Publicado: (2023)

Psychotic disorders in migrant population
por: Felgueiras, P., et al.
Publicado: (2021)

Nadie es ilegal : la lucha contra el racismo y la violencia de Estado en la frontera entre México y Estados Unidos /
por: Akers Chacón, Justin
Publicado: (2020)

Disorders Related to Use of Psychoactive Substances in DSM-5: Changes and Challenges
por: Bhad, Roshan, et al.
Publicado: (2015)

Psychoactive Prescribing in Assisted Living
por: Zimmerman, Sheryl, et al.
Publicado: (2020)

Trata de personas, migración ilegal y derecho penal /
por: Buompadre, Jorge E.
Publicado: (2009)

T54. TAILOR – TAPERED DISCONTINUATION VERSUS MAINTENANCE THERAPY OF ANTIPSYCHOTIC MEDICATION IN PATIENTS WITH NEWLY DIAGNOSED SCHIZOPHRENIA SPECTRUM DISORDERS IN REMISSION OF PSYCHOTIC SYMPTOMS
por: Dolmer, Signe, et al.
Publicado: (2018)

Differences in addictive beliefs in people with psychostimulant addiction and in opioid addicts
por: Yan, Y., et al.
Publicado: (2022)

Personalizing antipsychotic treatment: evidence and thoughts on individualized tailoring of antipsychotic dosage in the treatment of psychotic disorders
por: Wunderink, Lex
Publicado: (2019)

Novel Psychoactive Substances: The Razor’s Edge between Therapeutical Potential and Psychoactive Recreational Misuse
por: Correia, Beatriz, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jed6th1a3k78lbrlmdrjlo6f12